100 related articles for article (PubMed ID: 29388173)
1. Prescription of Benzodiazepines and Related Drugs in Patients with Mild Cognitive Deficits and Alzheimer's Disease.
Hessmann P; Dodel R; Baum E; Müller MJ; Paschke G; Kis B; Zeidler J; Klora M; Reese JP; Balzer-Geldsetzer M
Pharmacopsychiatry; 2019 Feb; 52(2):84-91. PubMed ID: 29388173
[TBL] [Abstract][Full Text] [Related]
2. The Incidence of Benzodiazepine and Related Drug Use in Persons with and without Alzheimer's Disease.
Saarelainen L; Taipale H; Koponen M; Tanskanen A; Tolppanen AM; Tiihonen J; Hartikainen S
J Alzheimers Dis; 2016; 49(3):809-18. PubMed ID: 26484930
[TBL] [Abstract][Full Text] [Related]
3. Risk of Hip Fracture in Benzodiazepine Users With and Without Alzheimer Disease.
Saarelainen L; Tolppanen AM; Koponen M; Tanskanen A; Sund R; Tiihonen J; Hartikainen S; Taipale H
J Am Med Dir Assoc; 2017 Jan; 18(1):87.e15-87.e21. PubMed ID: 27847263
[TBL] [Abstract][Full Text] [Related]
4. Antidepressant medication in a German cohort of patients with Alzheimer's disease
.
Hessmann P; Dodel R; Baum E; Müller MJ; Paschke G; Kis B; Zeidler J; Klora M; Reese JP; Balzer-Geldsetzer M
Int J Clin Pharmacol Ther; 2018 Mar; 56(3):101-112. PubMed ID: 29350177
[TBL] [Abstract][Full Text] [Related]
5. Impact of opioid initiation on antipsychotic and benzodiazepine and related drug use among persons with Alzheimer's disease.
Hamina A; Lavikainen P; Tanskanen A; Tolppanen AM; Tiihonen J; Hartikainen S; Taipale H
Int Psychogeriatr; 2018 Jul; 30(7):947-956. PubMed ID: 29559009
[TBL] [Abstract][Full Text] [Related]
6. The risk of Alzheimer's disease associated with benzodiazepines and related drugs: a nested case-control study.
Tapiainen V; Taipale H; Tanskanen A; Tiihonen J; Hartikainen S; Tolppanen AM
Acta Psychiatr Scand; 2018 Aug; 138(2):91-100. PubMed ID: 29851063
[TBL] [Abstract][Full Text] [Related]
7. Long-term use of benzodiazepines and related drugs among community-dwelling individuals with and without Alzheimer's disease.
Taipale H; Koponen M; Tanskanen A; Tolppanen AM; Tiihonen J; Hartikainen S
Int Clin Psychopharmacol; 2015 Jul; 30(4):202-8. PubMed ID: 26011780
[TBL] [Abstract][Full Text] [Related]
8. Risk of death associated with new benzodiazepine use among persons with Alzheimer disease: A matched cohort study.
Saarelainen L; Tolppanen AM; Koponen M; Tanskanen A; Tiihonen J; Hartikainen S; Taipale H
Int J Geriatr Psychiatry; 2018 Apr; 33(4):583-590. PubMed ID: 29143367
[TBL] [Abstract][Full Text] [Related]
9. Use of benzodiazepines and related drugs is associated with a risk of stroke among persons with Alzheimer's disease.
Taipale H; Koponen M; Tanskanen A; Lavikainen P; Tolppanen AM; Sund R; Tiihonen J; Hartikainen S
Int Clin Psychopharmacol; 2017 May; 32(3):135-141. PubMed ID: 28072593
[TBL] [Abstract][Full Text] [Related]
10. Use of antidementia drugs in German patients with Alzheimer's disease.
Hessmann P; Dodel R; Baum E; Müller MJ; Paschke G; Kis B; Zeidler J; Klora M; Reese JP; Balzer-Geldsetzer M
Int Clin Psychopharmacol; 2018 Mar; 33(2):103-110. PubMed ID: 29112517
[TBL] [Abstract][Full Text] [Related]
11. Antipsychotic treatment of community-dwelling and institutionalised patients with dementia in Germany.
Hessmann P; Dodel R; Baum E; Müller MJ; Paschke G; Kis B; Zeidler J; Klora M; Reese JP; Balzer-Geldsetzer M
Int J Psychiatry Clin Pract; 2018 Sep; 22(3):232-239. PubMed ID: 29235398
[TBL] [Abstract][Full Text] [Related]
12. Use of benzodiazepine and related drugs in migrants and Finnish-born persons: a nationwide register-based study.
Lehti V; Salama E; Niemelä S; Tanskanen A; Gissler M; Suvisaari J; Taipale H
Scand J Public Health; 2023 Dec; 51(8):1222-1230. PubMed ID: 35876428
[TBL] [Abstract][Full Text] [Related]
13. Concomitant use of benzodiazepines and opioids in community-dwelling older people with or without Alzheimer's disease-A nationwide register-based study in Finland.
Karttunen N; Taipale H; Hamina A; Tanskanen A; Tiihonen J; Tolppanen AM; Hartikainen S
Int J Geriatr Psychiatry; 2019 Feb; 34(2):280-288. PubMed ID: 30370943
[TBL] [Abstract][Full Text] [Related]
14. Factors associated with long-term benzodiazepine and Z-drug use across the lifespan and 5-year temporal trajectories among incident users: a Swedish nationwide register-based study.
Isomura K; Wang X; Chang Z; Hellner C; Hasselström J; Ekheden I; Jayaram-Lindström N; Lichtenstein P; D'Onofrio BM; Mataix-Cols D; Sidorchuk A
Eur J Clin Pharmacol; 2023 Aug; 79(8):1091-1105. PubMed ID: 37294340
[TBL] [Abstract][Full Text] [Related]
15. Do changes in specific cognitive functions predict changes in health-related quality of life in people with Alzheimer's disease?
Bosboom PR; Almeida OP
Int J Geriatr Psychiatry; 2014 Jul; 29(7):694-703. PubMed ID: 24273030
[TBL] [Abstract][Full Text] [Related]
16. Use of psychotropic medications in relation to neuropsychiatric symptoms, cognition and functional performance in Alzheimer's disease over a three-year period: Kuopio ALSOVA study.
Törmälehto S; Martikainen J; Bell JS; Hallikainen I; Koivisto AM
Int Psychogeriatr; 2017 Oct; 29(10):1723-1733. PubMed ID: 28625207
[TBL] [Abstract][Full Text] [Related]
17. Factors associated with quality of life in patients with Alzheimer's disease.
Barbe C; Jolly D; Morrone I; Wolak-Thierry A; Dramé M; Novella JL; Mahmoudi R
BMC Geriatr; 2018 Jul; 18(1):159. PubMed ID: 29986669
[TBL] [Abstract][Full Text] [Related]
18. [Differences Between Self- and Proxy-Assessment of Health-Related Quality of Life in Patients with Mild Cognitive Impairment and Alzheimer's Disease].
Heßmann P; Dreier M; Brandes I; Dodel R; Baum E; Müller MJ; Balzer-Geldsetzer M
Psychiatr Prax; 2018 Mar; 45(2):78-86. PubMed ID: 28241372
[TBL] [Abstract][Full Text] [Related]
19. Cognitive Impairment Precedes and Predicts Functional Impairment in Mild Alzheimer's Disease.
Liu-Seifert H; Siemers E; Price K; Han B; Selzler KJ; Henley D; Sundell K; Aisen P; Cummings J; Raskin J; Mohs R;
J Alzheimers Dis; 2015; 47(1):205-14. PubMed ID: 26402769
[TBL] [Abstract][Full Text] [Related]
20. Determinants of the quality of life in Alzheimer's disease patients as assessed by the Japanese version of the Quality of Life-Alzheimer's disease scale.
Matsui T; Nakaaki S; Murata Y; Sato J; Shinagawa Y; Tatsumi H; Furukawa TA
Dement Geriatr Cogn Disord; 2006; 21(3):182-91. PubMed ID: 16401890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
